Page breadcrumb nav

VAERS Report 2115806

Case Report Section

Détails du rapport Vaer

Âge: 59 ans

Genre: Female

Région : Massachusetts

Patient décédé?
Non
Renseignements sur les vaccins

Nom: VACCINE NOT SPECIFIED (NO BRAND NAME)

Type : Unknown vaccine type

Fabricant: UNKNOWN

Lot: unknown


Date de réception du rapport
2022-02-16
Date à laquelle le formulaire est complèté
Date de vaccination
2021-04-13
Date d’apparition
0
Nombre de jours (date d’apparition – date de vaccination)
0
Description de l’événement indésirable

had a drug interaction with pfizer covid-19; told that the drug interaction pfizer covid-19 affected her right hip.; she had debility with ambulation for 5 days; brain fog; pain; she was only capable of ambulating from bed to bathroom; this is a spontaneous report received from contactable reporter(s) (consumer or other non hcp). the reporter is the patient. other case identifier(s): nvsc2020us100435_ns. a 59 year-old female patient received bnt162b2 (bnt162b2), administration date 13apr2021 (batch/lot number: unknown) at the age of 59 years as dose 2, single for covid-19 immunisation. the patient's relevant medical history and concomitant medications were not reported. vaccination history included: bnt162b2 (first dose), administration date: 23mar2021, when the patient was 59 years old, for covid-19 immunization, reaction(s): "she had debility with ambulation"; bnt162b2 (first dose), administration date: 23mar2021, for covid-19 immunization, reaction(s): "pain", "brain fog". the following information was reported: asthenia (non-serious) with onset 2021, outcome "unknown", described as "she had debility with ambulation for 5 days"; feeling abnormal (non-serious) with onset 2021, outcome "unknown", described as "brain fog"; pain (non-serious) with onset 2021, outcome "unknown", described as "pain"; dyskinesia (non-serious) with onset 2021, outcome "unknown", described as "she was only capable of ambulating from bed to bathroom"; drug interaction (non-serious), outcome "unknown", described as "had a drug interaction with pfizer covid-19"; musculoskeletal discomfort (non-serious), outcome "unknown", described as "told that the drug interaction pfizer covid-19 affected her right hip.". relevant laboratory tests and procedures are available in the appropriate section. additional information: patient reported received 2 dose of pfizer vaccine, 1st dose on 23mar2021 and 2nd dose on 13apr2021, patient stated after first dose she had debility with ambulation, brain fog and pain for 2 days. with receiving 2nd dose, patient reported continuous brain fog, pain and of debility with ambulation for 5 days. she was only capable of ambulating from bed to bathroom. she had a drug interaction with pfizer covid-19, 2nd injection, which was admin 13apr2021. several mris and blood work was collected, and pt. was told that the drug interaction pfizer covid-19 affected her right hip. no follow-up attempts are possible; information about lot/batch number cannot be obtained. no further information is expected

Données de laboratoire
test date: 2021; test name: blood work; result unstructured data: test result:unknown results; test date: 2021; test name: mri; result unstructured data: test result:unknown results
Liste des symptômes
feeling abnormal drug interaction dyskinesia pain asthenia musculoskeletal discomfort magnetic resonance imaging blood test
Patient décédé?
Non
Date de décès
N/A
Anomalie congénitale
false
Vaccin administré par :
Unknown
Vaccin acheté par :
Inconnu
Visite d’un patient à l’urgence?
Non
Patient hospitalisé?
Non
Séjour à l’hôpital
Non
Nombre de jours à l’hôpital
Non spécifié
Invalidité permanente?
Non
Allergies:
na
Maladie actuelle
na